BridgeMD
New treatment option for Hereditary Spastic Paraparesis
Official title Evaluation of an Intensive Training Program for Patients with Hereditary Spastic Paraparesis SPG4/Spast
ClinicalTrials.gov ID: NCT06229626
What this study is testing
- What it's testing
- Hereditary spastic paraparesis is a group of inherited neurological diseases. Only symptomatic treatments exist for the moment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with molecular diagnosis of hereditary spastic paraparesis based on pathogenic variant of SPAST gene,
- Walking possible for 6 minutes without human assistance (one or more technical aids are authorized: e.g. cane, walker, orthoses),
- At least 1 physiotherapy session per week already in place.
- Understanding of the protocol
- Possibility of connecting to the Internet from home to access video material provided as part of the protocol.
You likely can't join if
- Botulinum toxin injection within 2 months of protocol inclusion
- Discontinuation of private physiotherapy,
- Refusal to participate in the protocol,
- Participation in another treatment clinical trial evaluating a health product or in a assigned by chance clinical trial
- Pregnant women
- Not affiliated to a social security scheme or beneficiary of such a scheme
See the full eligibility criteria
- Patient with molecular diagnosis of hereditary spastic paraparesis based on pathogenic variant of SPAST gene,
- Walking possible for 6 minutes without human assistance (one or more technical aids are authorized: e.g. cane, walker, orthoses),
- At least 1 physiotherapy session per week already in place.
- Understanding of the protocol
- Possibility of connecting to the Internet from home to access video material provided as part of the protocol.
- Botulinum toxin injection within 2 months of protocol inclusion
- Discontinuation of private physiotherapy,
- Refusal to participate in the protocol,
- Participation in another treatment clinical trial evaluating a health product or in a assigned by chance clinical trial
- Pregnant women
- Not affiliated to a social security scheme or beneficiary of such a scheme
- Patient under guardianship or trusteeship
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.